GlassScriptPhysician profile
Steven Zhang
NPI 1386104651
$5,805.94
in general payments reported to CMS, 2019-2025
18 companies · $3,029 in 2025
The $3,029 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $57.49 · 2021: $130 · 2022: $227 · 2023: $1,218 · 2024: $1,144 · 2025: $3,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,099 · Travel and Lodging: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,099.00 |
| Travel and Lodging | $1,291.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,947.59 | 2023-2025 | Infinity, Gallant, Ensite Precision |
| Medtronic, INC. | $1,523.98 | 2024-2025 | Cd Horizon Spinal System |
| Teva Pharmaceuticals USA, INC. | $523.15 | 2022-2025 | Austedo Xr, Austedo, Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $266.48 | 2021-2022 | |
| Stryker Corporation | $193.30 | 2024 | Mako, T2 Alpha |
| Boston Scientific Corporation | $187.78 | 2025 | Latitude Communicator Power Supply, Resonate El Icd Vr |
| Depuy Synthes Sales INC. | $171.64 | 2025 | Velys, Symphony, Trialtis |
| Elite Orthopedics, LLC | $163.46 | 2024 | |
| Augmedics INC. | $161.10 | 2025 | Xvision |
| Cerapedics INC. | $155.70 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Alphatec Spine, INC | $152.49 | 2025 | Other - Miscellaneous |
| Peter Brasseler Holdings, LLC | $101.73 | 2024 | |
| Medical Device Business Services, INC. | $78.53 | 2025 | Velys |
| Cardiva Medical, INC. | $67.94 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merz North America, INC. | $57.49 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paladin Technology Solutions | $21.22 | 2023 | |
| Globus Medical, INC. | $17.89 | 2024 | Captivate Vl |
| Cumberland Pharmaceuticals, INC. | $14.47 | 2024 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.